about
Interventions for hidradenitis suppurativaTopical treatments for chronic plaque psoriasisTopical treatments for chronic plaque psoriasisDefinition of treatment goals for moderate to severe psoriasis: a European consensusApremilast in the therapy of moderate-to-severe chronic plaque psoriasisManagement of psoriasis patients with hepatitis B or hepatitis C virus infectionCost-effectiveness of psoriasis therapy with etanercept in Germany.Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasisComorbidities and cardiovascular risk factors in patients with psoriasis.Which Psoriasis Patients Develop Psoriatic Arthritis?Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.Etanercept in psoriasis: the evidence of its therapeutic impact.Use of biologic agents in combination with other therapies for the treatment of psoriasisPsoriasis severity and hypothalamic-pituitary-adrenal axis function: results from the CALIPSO study.Clinical profile of childhood-onset psoriasis and prevalence of HLA-Cw6: a hospital-based study from India.Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features.Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation.Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus.Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis.Moderate and severe plaque psoriasis: cost-of-illness study in Italy.Treatment goals in psoriasis.Psoriasis: advances in pathophysiology and management.Psoriasis: consensus on topical therapies.Treatment of severe psoriasis with infliximab.Psoriasis--new insights into pathogenesis and treatment.Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach.Circulating adiponectin levels in Indian patients with psoriasis and its relation to metabolic syndrome.Strategies for improving the quality of care in psoriasis with the use of treatment goals--a report on an implementation meeting.Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England.Biological treatments for moderate-to-severe psoriasis: indirect comparison.Japanese guidance for use of biologics for psoriasis (the 2013 version).A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast.Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.Broader concepts of quality of life measurement, encompassing validation.
P2860
Q24186587-EB7178CF-CBE1-414F-83BC-B07AE4086136Q24198258-BADBB346-27BC-485B-850D-6A33B2BB6C41Q24241239-1A083DFD-187E-4081-89C4-6C1C842BEAF7Q24604445-AA7524E1-5A2F-4BF7-8038-29105F6D827CQ26745789-EEA58A2F-43D6-486B-A2A8-336F10EB5830Q28078157-2D15D9F8-71B3-46E3-990E-17C793CE48D4Q33296076-70924612-FA93-46A6-BB5C-A027C6A10256Q33650112-582C2D77-7EB4-40D4-933E-1402C34B647BQ33879351-D4C6D6D1-24CE-4FEC-AF51-B9D836E97C43Q34140480-C7262067-0630-4812-B7BA-A29E4C658993Q34386985-CADC964B-D0B7-4C0B-AD32-D39E3CF1A853Q34449302-D8D260F3-3557-4354-B56D-A88C8B0524D9Q34450544-E810766B-9AFB-4C3C-B37B-F9465F5E7B78Q34553755-08119448-45DE-4FE7-BA5A-2E136A3C751CQ34574306-6ABADB66-876B-4902-A393-E9B059A7D5DBQ35623494-DE141228-B7A0-4FA8-AD72-9A36296E3BB2Q35892189-9CA25CEA-9800-4D11-B23E-EFDC11A1758FQ36247035-605DF9B8-F3C5-4A38-BC7D-FA05E63412D2Q36572788-262E1C3C-1CC1-4AC4-8F53-250A36A11603Q36628064-DE53B150-8D33-4853-A227-D56D74C0535EQ36640532-78DF1FEB-760D-437D-B68C-712BE078A4D8Q36771864-73945015-CDFA-4385-9723-CCE8A9D665B9Q36823606-14E0ECFD-8E37-4F01-96C7-2C7765418D42Q36870158-B0348449-D9CD-45CE-A3B3-6B49C133F709Q36995858-B669B787-C593-43FA-B51C-C19A2B4F7154Q37032806-9D33FDDE-7BE0-4641-B242-B1A6A48F0879Q37098135-76DAABDE-E64C-447E-BE96-8C988941B8CEQ37224763-E28B3B4F-005C-4C8E-A8B3-4FFA281CA629Q37542804-57BD2F9C-7098-4A0E-8F58-F5681F48599BQ37703699-BD640063-2658-45EC-AC0A-4656E8A142D3Q37862369-7BA52FE0-4048-4DAB-A432-CE036B9AFC5EQ37980484-A4889231-DECD-4515-8E0A-82BF04E738FEQ38075573-A3EA82A8-7CB3-467F-A620-9DFC99389464Q38084746-1F3344A6-64A6-49C1-BBA9-F7F666EBEAC4Q38137283-4A393F09-B8E4-4E55-89AC-F00567DA923FQ38675867-41285880-3222-4E00-A769-A4D0180BC67CQ38712213-A46FCCF0-3731-4D8E-9E8A-67C564BD7069Q38764670-3ED45276-D821-40FA-B487-4301B0A10A88Q39174490-5DC24A23-E748-45E2-B07E-BDF74EC6AC71Q39215992-562AA3A5-1983-44C9-B8AF-C5F28AA9EB3A
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current severe psoriasis and the rule of tens.
@ast
Current severe psoriasis and the rule of tens.
@en
type
label
Current severe psoriasis and the rule of tens.
@ast
Current severe psoriasis and the rule of tens.
@en
prefLabel
Current severe psoriasis and the rule of tens.
@ast
Current severe psoriasis and the rule of tens.
@en
P2860
P1476
Current severe psoriasis and the rule of tens
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2005.06502.X
P407
P577
2005-05-01T00:00:00Z